Yasunobu Mano

Dr. Yasunobu Mano

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2013 in PLOS Biology
Verified
Journal Article
Open access
PDF file
YMYasunobu Mano
Yasunobu Mano
TKTetsuya J Kobayashi
Tetsuya J Kobayashi
JNJun-ichi Nakayama
Jun-ichi Nakayama
HUHiroyuki Uchida
Hiroyuki Uchida
MOMasaya Oki
Masaya Oki
Differences in gene expression between individual cells can be mediated by epigenetic regulation; thus, methods that enable detailed analyses of single cells are crucial to understanding this phenomenon. In this study, genomic silencing regions of Saccharomyces cerevisiae that are subject to epigenetic regulation, including the HMR, HML, and telomere regions, were investigated using a newly developed single cell analysis method. This method uses fluorescently labeled proteins to track changes in gene expression over multiple generations of a single cell. Epigenetic control of gene expression differed depending on the specific silencing region at which the reporter gene was inserted. Correlations between gene expression at the HMR-left and HMR-right regions, as well as the HMR-right and HML-right regions, were observed in the single-cell level; however, no such correlations involving the telomere region were observed. Deletion of the histone acetyltransferase GCN5 gene from a yeast strain carrying a fluorescent reporter gene at the HMR-left region reduced the frequency of changes in gene expression over a generation. The results presented here suggest that epigenetic control within an individual cell is reversible and can be achieved via regulation of histone acetyltransferase activity. Although eukaryotic gene repression usually acts on individual genes, cells can also repress larger chromosomal regions via the establishment of a high order chromatin structure called heterochromatin. Once initiated, heterochromatin spreads until halted by a boundary, and in this study we focus on how this boundary is formed. Because the mechanism is epigenetic and can differ from cell to cell, we wanted to assess the dynamics of the process by tracking individual cells over multiple generations. Here we develop a novel method employing protein fluorescence to monitor gene expression at the boundaries of several yeast heterochromatic regions simultaneously. This allows us to assess whether different boundaries within a single cell fluctuate in concert or independently of each other. In addition, we use histone modification mutants to probe the specific types of epigenetic regulation responsible for fluctuations in heterochromatin boundary positioning. Using this method, we show that epigenetic gene expression within individual cells is reversible and that this process is regulated by histone acetylation state. Future work will identify connections between variation in boundary positioning and novel transcription control systems.

12 August 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
SHShun Horaguchi
Shun Horaguchi
YNYoshiro Nakahara
Yoshiro Nakahara
YIYuka Igarashi
Yuka Igarashi
TKTaku Kouro
Taku Kouro
FWFeifei WEI
Feifei WEI
Tetsuro SasadaTetsuro Sasada
Tetsuro Sasada
Neutrophil extracellular traps (NETs) released from neutrophils are related to cancer progression. However, the relationship between the therapeutic effects of immune checkpoint inhibitors (ICIs) such as anti-PD-1 and anti-PD-L1 antibodies and plasma NET concentration in patients with non-small cell lung cancer (NSCLC) is poorly understood. In this study, concentrations of citrullinated histone H3 (CitH3), a surrogate marker of NETs, in plasma before/after treatment were examined in patients with advanced or recurrent NSCLC undergoing ICI treatment (n = 185). The clinical significances of NET levels before/after treatment and posttreatment changes were statistically evaluated. As a result, multivariate Cox analysis showed that high NET levels before treatment were statistically significant predictors of unfavorable overall survival (OS; p < 0.001, HR 1.702, 95% CI 1.356–2.137) and progression-free survival (PFS; p < 0.001, HR 1.566, 95% CI 1.323–1.855). The Kaplan-Meier curves showed significant separation between the high- and low-NET groups in OS (p = 0.002) and PFS (p < 0.001). Additionally, high NET levels after treatment were also significantly associated with worse OS (p < 0.001) and PFS (p < 0.001) by multivariate Cox analysis. Notably, the pretreatment NET levels were significantly correlated with the plasma levels of NET-related inflammatory cytokines, such as IL-6 and IL-8, and with NET-related gene expression and immune-suppressive profile in peripheral blood mononuclear cells. Our findings suggest that NETs released from activated neutrophils might reduce the clinical efficacy of ICIs in patients with NSCLC.

11 November 2022 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
TITakato Inoue
Takato Inoue
KMKazuaki Matsuda
Kazuaki Matsuda
KMKeisuke Matsusaka
Keisuke Matsusaka
MNMasaya Nakajima
Masaya Nakajima
YTYukari Takeno
Yukari Takeno
AKAtsushi Kaneda
Atsushi Kaneda

23 May 2026 in Small Science
Verified
Journal Article
Open access
PDF file
KHKazuma Handa
Kazuma Handa
TKTakuji Kawamura
Takuji Kawamura
YMYasunobu Mano
Yasunobu Mano
HNHideyuki Nakanishi
Hideyuki Nakanishi
LFLisa Fujimura
Lisa Fujimura
SMShigeru Miyagawa
Shigeru Miyagawa
Pathological remodeling after myocardial infarction (MI) involves multifactorial mechanisms, highlighting the need for combinatorial therapeutic strategies. Synthetic mRNAs offer design flexibility and represent a modality particularly suitable for such approaches. To investigate this, five genes ( Hgf , Igf1 , Pdgfb , Cxcl12 , and Tgfβ1 ) were selected from a model in which extracellular vesicles secreted by human iPSC‐derived cardiomyocytes restored cardiac function. Synthetic mRNAs encoding these genes were delivered via polyplex nanomicelles by direct myocardial administration in mice with MI‐induced heart failure. Nanomicelles have been shown to provide stable encapsulation, enhanced local expression, and prolonged persistence. This treatment promoted angiogenesis via the PI3K–Akt–ETV4 axis, suppressed fibrosis via inhibition of the JNK/FOXO3 pathway, and enhanced repair by activating ERK signaling, together yielding multifaceted benefits, including tissue regeneration, improved contractility, and extended survival. These findings establish the therapeutic potential of multigene mRNA cocktail therapy for post‐MI heart failure and mark an important step toward developing new interventions for diseases characterized by complex remodeling.

9 October 2025 in The Journal of Pathology
Verified
Journal Article
Closed access
YMYasunobu Mano
Yasunobu Mano
KMKeisuke Matsusaka
Keisuke Matsusaka
MSMotoaki Seki
Motoaki Seki
KKKazuko Kita
Kazuko Kita
MFMasaki Fukuyo
Masaki Fukuyo
AKAtsushi Kaneda
Atsushi Kaneda